TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT)

BMC Cardiovascular Disorders

Volumn 10, Issue , 2010, Pages

  Smith, Danielle E ^a,b   Xuereb, Christian B ^a,b   Pattison, Helen M ^b   Lip, Gregory Y H ^a,b   Lane, Deirdre A ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

ANAMNESIS; ANTICOAGULANT THERAPY; ANXIETY; ARTICLE; BLEEDING; CAUSE OF DEATH; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOCUMENTATION; DRUG USE; ELECTROCARDIOGRAM; HEALTH BELIEF; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; OUTCOME ASSESSMENT; PATIENT EDUCATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; STROKE; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; VALVULAR HEART DISEASE; COST; DISEASE COURSE; ECONOMICS; FOLLOW UP; PATHOPHYSIOLOGY; SOCIOECONOMICS; TREATMENT OUTCOME; UNITED KINGDOM;

ANTICOAGULANTS; ATRIAL FIBRILLATION; COSTS AND COST ANALYSIS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INTERNATIONAL NORMALIZED RATIO; PATIENT EDUCATION AS TOPIC; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; WARFARIN;

EID: 77954063031     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-10-21     Document Type: Article

References (23)

1. Lloyd-Jones DM, Wang TJ, Leip EP. Lifetime risk for developing atrial fibrillation: The Framingham Heart Study. Circulation 2004, 110:1042-1046. 10.1161/01.CIR.0000140263.20897.42, 15313941.
2. Lip GYH, Edwards SJ. Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: A systematic review and meta-analysis. Thrombo Res 2006, 110:354-358.
3. Steger C, Pratter A, Martinek-Bregel M. Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke Registry. Eur Heart J 2004, 25:1734-1740. 10.1016/j.ehj.2004.06.030, 15451152.
4. Hart RG, Pearce LA, Aguillar ML. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007, 146:857-867.
5. Nieuwlaat R, Capucci A, Lip GYH. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2006, 27:3018-3026. 10.1093/eurheartj/ehl015, 16731536.
6. van Walraven C, Hart RG, Singer DE. Oral anticoagulants vs. aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 2002, 288:2441-2448. 10.1001/jama.288.19.2441, 12435257.
7. Jones M, McEwan P, Morgan CL. Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population. Heart 2005, 91:472-477. 10.1136/hrt.2004.042465, 1768813, 15772203.
8. Connolly SJ, Pogue J, Eikelboom J. Benefit of oral anticoagulation over antiplatlet therapy in atrial fibrillation depends upon the quality of the international normalised ratio achieved by centres and countries as measured by time in therapeutic range. Cirulation 2008, 118:2029-2037.
9. Morgan CLI, McEwan P, Tukiendorf A. Warfarin tratment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control. Thrombo Res 2009, 124:37-41.
10. Howitt A, Armstrong D. Implementing evidence based medicine in general practice: audit and quality of antithrombotic treatment for atrial fibrillation. BMJ 1999, 318:1324-1327. 27873, 10323820.
11. Protheroe J, Fahey T, Montgomery A. The impact of patients' preferences on the treatment of atrial fibrillation: an observational study of patients bases decision analysis. BMJ 2000, 320:1380-1384. 10.1136/bmj.320.7246.1380, 27382, 10818030.
12. Bungard TJ, Ghali WA, Teo KK. Why do patients with atrial fibrillation not recieve warfarin. Arch of Intern Med 2000, 160:46-41.
13. Tang E, Lai C, Lee K. Relationships between patients' warfarin knowledge and anticoagulation control. Ann Pharm 2003, 37:34-39.
14. Lane DA, Ponsford J, Shelley A. Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: Effects of an educational intervention programme The West Birmingham Atrial Fibrillation Project. Int J Cardiol 2006, 110:354-358. 10.1016/j.ijcard.2005.07.031, 16253356.
15. Coelho-Dantas G, Thompson BV, Manson JA. Patients' perspectives on taking warfarin: qualitative study in family practice. BMC Fam Pract 2004, 5:15. 10.1186/1471-2296-5-15, 509246, 15268764.
16. Nadar S, Begum N, Kaur B. Patients' understanding of anticoagulation therapy in multiethinic population. J Royal Soc Med 2003, 96:175-179.
17. Khan TI, Kamali F, Kesteven P. The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. Br J Haematol 2004, 126:557-564. 10.1111/j.1365-2141.2004.05074.x, 15287950.
18. NICE Atrial fibrillation: national clinical guideline for management in primary and secondary care 2006, Royal College of Physicians, London, NICE.
19. Fuller R, Dudley N, Blacktop J. Avoidance hierarchies and preferences for anticoagulation--semi-qualitative analysis of older patients' views about stroke prevention and the use of warfarin. Age Ageing 2004, 33:608-611. 10.1093/ageing/afh202, 15385273.
20. Horne R, Weinman J, Hankins M. The Beliefs about Medicines Questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999, 14:1-24.
21. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983, 67:361-370. 10.1111/j.1600-0447.1983.tb09716.x, 6880820.
22. Weinman J, Petrie KJ, Moss-Morris R. The illness perception questionairre: a new method for assessing the cognitive representation of illness. Psychol Health 1996, 11:431-446.
23. Jowett S, Bryan S, Mahe I. A multinational investigation of time and travelling costs in attending anticoagulation clinics. Value in Health 2008, 11(2):207-212. 10.1111/j.1524-4733.2007.00253.x, 18380632.